PW01-037 – Amyloidosis probability depending on MEFV type

por Simonyan, A, Ayvazyan, A, Vardanyan, V, Kozlovskaya, L, Rameev, V
Publicado 2013

Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain

por Vorovitch, M. F., Kozlovskaya, L. I., Romanova, L. Iu., Chernokhaeva, L. L., Ishmukhametov, A. A., Karganova, G. G.
Publicado 2015

New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2

por Maslova, A. A., Matyugina, E. C., Shustova, E. Yu., Volok, V. P., Kozlovskaya, L. I., Kochetkov, S. N., Khandazhinskaya, A. L.
Publicado 2022

Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2

por Matyugina, E. S., Novikov, M. S., Kozlovskaya, L. I., Volok, V. P., Shustova, E. Y., Ishmukhametov, A. A., Kochetkov, S. N., Khandazhinskaya, A. L.
Publicado 2021

Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor

por Bibilashvili, R. Sh., Sidorova, M. V., Dudkina, U. S., Palkeeva, M. E., Molokoedov, A. S., Kozlovskaya, L. I., Egorov, A. M., Ishmukhametov, A. A., Parfyonova, E.V.
Publicado 2021

Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain

por Sidorova, M. V., Bibilashvili, R. S., Avdeev, D. V., Kozhokar, U. S., Palkeeva, M. E., Ovchinnikov, M. V., Molokoedov, A. S., Shirokov, D. A., Semyonova, A. V., Uvarova, V. I., Kulyaev, P. O., Khvatov, E. V., Ignatova, A. A., Feofanov, A. V., Osolodkin, D. I., Porozov, Yu. B., Kozlovskaya, L. I., Ishmukhametov, A. A., Parfyonova, Ye. V., Egorov, A. M.
Publicado 2022